MMRF PRESS RELEASES
Multiple Myeloma Research Foundation Chicago Awards Dinner Raises More Than $750,000 for Myeloma Research
CHICAGO — May 1, 2008
(BUSINESS WIRE)--The Multiple Myeloma Research Foundation raised $750,000 to advance research and drug development in the field of multiple myeloma, an incurable blood cancer, at the 7th annual Chicago Awards Dinner. More than 500 local business executives joined the MMRF and Connie L. Lindsey, Executive Vice President Northern Trust Corporation and Corporate Chair of the event, on April 23, 2008, at the Four Seasons Hotel.
Diahann Carroll provided the evening's keynote address, highlighting her personal journey with cancer and underscoring the importance of the MMRF's work in breaking down barriers to cancer research and drug development.
Bonnie Hunt, comedienne, actress and six-time mistress of ceremonies for the foundation's Chicago Awards Dinner, expressed her admiration for the MMRF noting, "Under Kathy Giusti's leadership, MMRF research partnerships have positively impacted the lives of myeloma and cancer patients around the world."
"The MMRF is proud that more than 93 percent of the money raised at this event will support innovative myeloma research and the development of new and effective treatment options," said MMRF Founder and CEO, Kathy Giusti, who is also a myeloma patient. Ms. Giusti received a warm introduction from Olympic gold medalist Scott Hamilton, a two-time cancer survivor, supporter and friend of the MMRF. Hamilton was honored at the 2007 Chicago Awards Dinner for his courage and commitment to raising awareness for cancer research.
Vice Chairs of the event include The Damico Family Foundation, Jane and Bob DeBaun, Brian J. Feltzin, Sheffield Asset Management, LLC; Joseph M. Hogan, GE Healthcare; Becky and Lester Knight; Michael D. O'Halleran, Aon Corporation; William A. Osborn, Northern Trust Corporation; McNamara Purcell Foundation; Edward J. Phillips, Edward and Leslye Phillips Family Foundation; Michael J. Sacks, Grosvenor Capital Management, L.P.
About Multiple Myeloma
Multiple myeloma is an incurable cancer of the plasma cell. The five-year relative survival rate for multiple myeloma is approximately 33%, one of the lowest of all cancers. In 2007, an estimated 19,900 adults (10,960 men and 8,940 women) in the United States were diagnosed with multiple myeloma and an estimated 10,790 people died from the disease.
About the Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to urgently and aggressively fund research that will lead to the development of new treatments for multiple myeloma. As the world's number-one funder of multiple myeloma research, the MMRF has raised nearly $100 million since its inception to fund 70 laboratories worldwide. The payback on its investment has been significant, including the approval of four new treatments in four years alone. Today, the MMRF is supporting 30 new compounds and approaches now in clinical trials and pre-clinical studies and has facilitated 10 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC).
For more information about the MMRF, please visit www.themmrf.org.